Status:
COMPLETED
A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Spinal Cord Injury
Erectile Dysfunction
Eligibility:
MALE
19+ years
Phase:
PHASE4
Brief Summary
To demonstrate the efficacy, safety and tolerability of sildenafil administered orally, as required, approximately 1 hour prior to sexual activity to men with erectile dysfunction (ED) associated with...
Eligibility Criteria
Inclusion
- Patients were men with spinal cord injury and erectile dysfunction
Exclusion
- N/A
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2003
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00654082
Start Date
September 1 2002
End Date
August 1 2003
Last Update
February 1 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bahçelievler, Istanbul, Turkey (Türkiye), 34580
2
Pfizer Investigational Site
Balçova, İzmir, Turkey (Türkiye)
3
Pfizer Investigational Site
Ankara, Turkey (Türkiye)
4
Pfizer Investigational Site
Bursa, Turkey (Türkiye)